Outcome of 08th Board meeting for FY 2025-26 through video conferencing without intimation for the following agendas: Approved the formation of a subsidiary of the company; To consider ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd's Board of Directors, at a meeting held on January 27, 2026, approved the formation of a new subsidiary company. The board also approved the re-constitution of the Internal Complaint Committee (ICC) and a revision to the company's POSH (Prevention of Sexual Harassment) Policy. The board meeting was held without prior intimation to the stock exchange. No financial details, names, or capital structure of the proposed subsidiary have been disclosed in this filing.
The subsidiary formation signals a potential business expansion or diversification move, but with no details on size, purpose, or capital involved, the immediate impact on shareholders is unclear. Investors should watch for further disclosures on the subsidiary's business plan and financial implications.